Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience.

Date publication

juin 2014

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier , Mme POZET Astrid

Tous les auteurs :
de Mestier L, Neuzillet C, Pozet A, Desot E, Deguelte-Lardière S, Volet J, Karoui M, Kianmanesh R, Bonnetain F, Bouché O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/24630774

Résumé

To explore the survival impact of primary tumor resection (PTR) in patients with metastatic colon cancer (mCC) and unresectable metastases.

Mots clés

Aged, Antineoplastic Agents, therapeutic use, Colonic Neoplasms, drug therapy, Female, Humans, Male, Middle Aged, Neoplasms, Multiple Primary, drug therapy, Propensity Score, Retrospective Studies, Survival Rate, Treatment Outcome

Référence

Eur J Surg Oncol. 2014 Jun;40(6):685-91